Centiva Capital, LP
Source: SEC Form 13F · as of Mar 2026Centiva Capital, LP holds 23 biotech & pharma companies tracked by BioSniper, totaling $34.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$34.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 14,610 | $11.3M |
| ABVXAbivax SA | 57,150 | $6.4M |
| TERNTerns Pharmaceuticals, Inc. | 101,225 | $5.3M |
| SLNOSOLENO THERAPEUTICS INC | 101,234 | $3.4M |
| MANEVeradermics Incorporated | 20,000 | $1.3M |
| CTMXCytomX Therapeutics, Inc. | 200,000 | $940K |
| RGNXREGENXBIO Inc. | 100,000 | $838K |
| RVMDREVOLUTION MEDICINES, INC. | 7,525 | $732K |
| PLRXPLIANT THERAPEUTICS, INC. | 432,525 | $545K |
| VKTXViking Therapeutics, Inc. | 13,258 | $431K |
| QNRXQuoin Pharmaceuticals, Ltd. | 60,000 | $396K |
| INSMINSMED Inc | 2,347 | $384K |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 4,000 | $348K |
| ANTXAN2 Therapeutics, Inc. | 75,000 | $257K |
| GILDGILEAD SCIENCES, INC. | 1,652 | $230K |
| AXSMAxsome Therapeutics, Inc. | 1,288 | $218K |
| OCULOCULAR THERAPEUTIX, INC | 25,000 | $212K |
| ROIVRoivant Sciences Ltd. | 7,596 | $210K |
| CYTKCYTOKINETICS INC | 3,000 | $198K |
| ABSIAbsci Corporation | 50,000 | $150K |
| MRNAModerna, Inc. | 2,733 | $139K |
| AARDAardvark Therapeutics, Inc. | 24,782 | $93K |
| RNAAtrium Therapeutics Inc. | 5,895 | $79K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.